In animal cells, recruitment of phosphatidylinositol 3-kinase by growth factor receptors generates 3-phosphoinositides, which stimulate 3-phosphoinositide-dependent protein kinase-1 (PDK1). Activated PDK1 then phosphorylates and activates downstream protein kinases, including protein kinase B (PKB)/c-Akt, p70 S6 kinase, PKC isoforms, and serum-and glucocorticoid-inducible kinase (SGK), thereby eliciting physiological responses.
Background
Receptor-mediated activation of phosphatidylinositol (PI) 3-kinase in animal cells stimulates a recently identified 3-phosphoinositide-dependent protein kinase, termed PDK1 (for review, see [1, 2] ). This enzyme was first identified [3, 4] by its ability to activate protein kinase B (PKB) [5] , also called RAC (for related to PKA and PKC) kinase [6] , and known also as the cellular homologue (c-Akt) of a retroviral oncoprotein, v-Akt [7] . PDK1 activates all known isoforms of PKB/c-Akt by phosphorylating a threonine residue in a conserved sequence motif (T Th hr r-Phe-CysGly-Thr-X-Glu-Tyr, where the bold Thr represents the phosphorylated residue and X represents any amino acid) located within the 'activation loop' of the catalytic domain, situated between the conserved protein kinase subdomains VII and VIII [8] . This residue corresponds to Thr308 in PKBα, Thr309 in PKBβ, and Thr305 in PKBγ [9] .
PDK1 is a monomeric 63 kDa enzyme comprising an amino-terminal catalytic domain and a carboxy-terminal extension containing a pleckstrin homology (PH) domain that binds PI 3,4,5-trisphosphate (PI(3,4,5)P 3 ) or PI 3,4-bisphosphate (PI(3,4)P 2 ) or, more weakly, PI(4,5)P 2 [10, 11] . PI(3,4,5)P 3 is generated from PI(4,5)P 2 by PI 3-kinase, and can be converted to PI(3,4)P 2 or PI(4,5)P 2 by different classes of 5-and 3-phosphoinositide phosphatases [12, 13] . Like PDK1, PKB contains a PH domain specific for PI(3,4,5)P 3 and PI(3,4)P 2 [14, 15] , although in PKB it is located at the amino terminus. The PH domain of PKB blocks access to the phosphorylation site in the carboxyterminal catalytic domain and this inhibition is relieved upon binding of lipids to the PH domain. Correspondingly, PKB is only activated by PDK1 in vitro in the presence of lipid vesicles containing PI(3,4,5)P 3 or PI(3,4)P 2 (for review, see [16, 17] ).
Since its discovery, PDK1 has been shown to phosphorylate other classes of protein kinases in vitro and cumulative evidence indicates that PDK1 is responsible for activating these enzymes in vivo. Thus, PDK1 may serve as a central integrator for signalling events from receptors that stimulate PI 3-kinase. Additional PDK1 targets elucidated to date include: p70 S6 kinase [18, 19] ; at least two PKC isoforms [20, 21] ; the catalytic subunit of cAMP-dependent protein kinase (PKA) [22] ; and, most recently, serum-and glucocorticoid-inducible kinase (SGK) [23] . All of these enzymes contain in their activation loop the conserved phosphorylation sequence first found in PKB/c-Akt and are phosphorylated by PDK1 at the corresponding threonine residue. Hence, this motif has been termed the PDK1 site. Full activation of PKB, however, also requires phosphorylation at a second site, Ser473, situated in a hydrophobic motif (Phe-X-X-Ar-S Se er r/ /T Th hr r-Ar, where the bold residue is the phosphorylated amino acid and Ar represents an aromatic residue) towards the carboxyl terminus [24] . Phosphorylation at this second site in PKB in vivo is prevented by inhibitors of PI 3-kinase [24] . This second motif is also conserved in the other PDK1-activated protein kinases listed above (except for PKA) and lies at a roughly equivalent position carboxy-terminal to the PDK1 site [20, 25, 26] . Neither purified nor recombinant PDK1 phosphorylates this second site [3, 27] , suggesting that this event requires either modification of the activity of PDK1 or a distinct enzyme, provisionally termed PDK2.
If PDK1 and its target protein kinases perform functions vital to signalling in all eukaryotic cells, then these molecules should be evolutionarily conserved. We have shown previously that a PDK1-like enzyme is present in the fruit fly, Drosophila melanogaster [27] . Here, we demonstrate both genetically in vivo and biochemically in vitro that PDK1-like and SGK-like protein kinases are present in budding yeast, Saccharomyces cerevisiae, and that these kinases are essential for cell growth and viability. Additional findings suggest that, as in animal cells, the PDK1-like enzymes are likely to play a role in activating other classes of protein kinases, in addition to the SGK-like enzymes.
Results

PKH1 and PKH2 encode homologues of mammalian PDK1
The S. cerevisiae genome contains two, previously uncharacterised, open reading frames (YDR490c and YOL100w) that encode protein kinases whose catalytic domains are 72% identical and share 50% identity with either human or Drosophila PDK1 (Figure 1a ). These loci were designated PKH1 and PKH2, respectively (for PKB-activating kinase homologues 1 and 2). PKH1 is located on the right arm of chromosome IV [28] and encodes a 766-residue protein (86 kDa); PKH2 is situated on the left arm of chromosome XV [29] and encodes a 1,081-residue protein (121 kDa). Pkh1 and Pkh2 contain both amino-terminal and carboxyterminal extensions to the catalytic domain ( Figure 1b ) and are much less similar to each other (only 27% identity) in these regions. These regions display no apparent similarity with the non-catalytic regions of PDK1 or with other known proteins. In particular, Pkh1 and Pkh2 lack any obvious PH domain, unlike human and Drosophila PDK1 which have a PH domain at their carboxyl terminus.
PKH1 and PKH2 are essential genes that are functionally redundant
To determine whether the genes PKH1 and PKH2 encode expressed proteins, the effect of loss-of-function mutations in these loci was examined. Each open reading frame was deleted and replaced with a selectable marker (TRP1 for PKH1 and HIS3 for PKH2). The resulting alleles, pkh1∆::TRP1 and pkh2∆::HIS3, were used to replace the normal chromosomal loci by homologous recombination. Both a haploid pkh1∆::TRP1 mutant strain (AC301) and a haploid pkh2∆::HIS3 mutant strain (AC303) grew normally and indistinguishably from congenic PKH1 + and PKH2 + haploids isolated from the same tetrad. Also, pkh1∆ and pkh2∆ single mutants displayed no apparent phenotype when challenged by high concentrations of salt or caffeine, various carbon sources, different temperatures, or when subjected to heat shock. To determine whether PKH1 and PKH2 have a common function, the AC301 strain was crossed with the AC303 strain. Upon sporulation of the resulting doubly heterozygous diploid (AC306), the majority of the 30 tetrads dissected yielded three viable spores and one non-viable spore. The viable spores were analysed both by plating on appropriate selective media and by PCR. None of the viable haploid cells were Trp + and His + , and none carried both the pkh1∆ and the pkh2∆ mutations. Microscopic observation of the non-viable spores revealed that most germinated and underwent 2-3 cycles of cell division before ceasing to grow. Hence, pkh1∆ pkh2∆ double mutants are inviable, indicating that PKH1 and PKH2 encode genes that are functionally redundant and share some role that is essential for cell growth and survival.
To confirm that the lethality of pkh1∆ pkh2∆ cells is due solely to the absence of PKH1 or PKH2 function, the doubly heterozygous diploid strain AC306 was transformed with either YEplac195-PKH1, a URA3-marked plasmid expressing PKH1 from its own promoter, or the empty vector (YEplac195), and the resulting Ura + transformants were subjected to sporulation and tetrad dissection. Many Trp + His + and Ura + spore clones were obtained from the diploid strain transformed with YEp195-PKH1, but not from that transformed with empty vector (data not shown). Thus, the pkh1∆ pkh2∆ double mutant was able to survive if PKH1 expression was restored. Likewise, when AC306 was transformed with a URA3-marked plasmid (pYES2) expressing either PKH1 (Figure 2a ) or PKH2 (data not shown) from the GAL1 promoter, it was possible to obtain viable pkh1∆ pkh2∆ spores, even when the cells were propagated on glucose (presumably because these constructs are not efficiently repressed on this carbon source [30] ). Most significantly, when the pkh1∆ pkh2∆ cells harbouring pYES2-PKH1 (Figure 2a ) or pYES2-PKH2 (data not shown) were plated on medium containing 5-fluoroorotic acid (5-FOA), which selects for cells that lack a functional URA3 gene [31] and, hence, for loss of the URA3-marked plasmid, the pkh1∆ pkh2∆ cells were no longer capable of growing (Figure 2a ).
Human PDK1 is a functional homologue of Pkh1 and Pkh2
To determine whether Pkh1 and Pkh2 are similar to PDK1 in function, as well as in sequence, the AC306 strain was transformed with YEplac195 plasmids containing genes encoding either full-length human PDK1 or human PDK1 lacking the carboxy-terminal PH domain Comparison of the primary structures of Pkh1 and Pkh2 with PDK1. (a) Alignment of the deduced amino-acid sequences of yeast Pkh1 and Pkh2 with the catalytic domains of human PDK1 and its Drosophila homologue, DSTPK61 [27] , carried out using the CLUSTAL W program. Identical residues are denoted by white letters on a black background, and similar residues by white letters on a grey background. Dashes represent gaps introduced in the sequences to optimise the alignment. Five independent PKH1 clones that we generated by PCR all differed from the sequence deposited in the Saccharomyces Genome Database, indicating that Phe187 (nucleotide sequence TTC) should actually be an isoleucine residue (ATC). (b) Schematic diagrams of the structures of the PDK1-related proteins. Dark grey boxes indicate the catalytic domain in each protein kinase and light grey boxes indicate PH domains.
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Figure 2
Loss of both PKH1 and PKH2 causes inviability and either intact human PDK1 or PDK1-∆PH can restore viability to pkh1∆ pkh2∆ cells. (a) Four spores (wild type (wt); pkh1∆; pkh2∆; and pkh1∆ pkh2∆) derived from a tetratype ascus of diploid strain AC306 that had been transformed with plasmid pYES2-PKH1 (which is marked with URA3) were plated either on medium lacking uracil (SD-Ura) to select for the presence of the plasmid, or on medium containing 5-FOA to select for loss of the plasmid [31] . (b) Four spores, as in (a), derived from a tetratype ascus of strain AC306 that was transformed with either YEplac195-PDK1 or YEplac195-PDK1-∆PH (which are marked with URA3), as indicated, were plated either on medium lacking uracil (SD-Ura) to select for the presence of the plasmids (only one representative plate is shown), or on medium containing 5-FOA to select for loss of the plasmids. with GST-Pkh1, as indicated, in the presence of 100 µM ATP, with or without phospholipid vesicles containing 100 µM phosphatidylcholine,radioactivity was released after one cycle of Edman degradation (data not shown). This analysis establishes that yeast Pkh1 phosphorylates PKBα at Thr308.
YPK1 and YKR2 encode homologues of mammalian SGK
PKBα is one founding member of the so-called AGC subfamily of protein kinases, several of which possess the conserved PDK1 phosphorylation site in their activation loop and a distal PDK2 phosphorylation site (Figure 4a ). There are four previously characterised protein kinases in S. cerevisiae that possess both motifs (Figure 4a ), suggesting that one or more might be physiological substrates for Pkh1 and/or Pkh2. These four protein kinases are the products of the YPK1 [33] , YKR2/YPK2 [34, 35] , SCH9 [36] , and PKC1 [37] genes. Ypk1 and Ykr2 are 88% identical in their catalytic domains and have extensive similarities across their amino-terminal and carboxy-terminal extensions (Figure 4b ). Among mammalian protein kinases, the catalytic domains of Ypk1 and Ykr2 share greatest similarity to SGK (55% identity), PKB/c-Akt (52% identity), p70 S6 kinase (50% identity) and βARK (38% identity; Figure 4b ). Although βARK is considered to be an AGC family member [38] , it lacks the PDK1 and PDK2 motifs.
YPK1 and YKR2 are essential genes that are functionally redundant
Cells lacking either Ypk1 or Ykr2 are viable, whereas cells lacking both Ypk1 and Ykr2 are inviable [35] . We established conditions for testing the ability of potential mammalian homologues to rescue this inviability. For this purpose, otherwise isogenic ypk1∆::HIS3 and ykr2∆::TRP1 haploid strains (YES5 and YES1, respectively) were crossed and the resulting diploid strain (YES7) was transformed with a LEU2-marked plasmid expressing the YKR2 gene under the tight control of the GAL1 promoter. When subjected to sporulation and tetrad dissection on galactose-containing medium, most of the tetrads yielded four viable spores, and His + Trp + Leu + isolates were readily 190 Current Biology, Vol 9 No 4
Figure 4
Consensus sites for PDK1-dependent and PDK2-dependent phosphorylation, and comparison of the primary structures of Ypk1 and Ykr2 with their closest mammalian homologues. (a) Conserved motifs predicted to be phosphorylated by PDK1-like and PDK2-like enzymes are indicated with the residue phosphorylated shown in bold type. In all cases, the putative PDK2 phosphorylation site is located 157-166 residues carboxyterminal to the PDK1 phosphorylation site. GenBank accession numbers: PKBα, X65687; SGK, Y10032; p70 S6Kα, M60725; PKCζ, L07032; Ypk1, P12688; Ykr2, P18961; Pkc1, M32491; and Sch9, U00029. (b) Alignment of Ypk1 and Ykr2 to each other and to mammalian SGK, PKBα, p70 S6 kinase (S6K) and βARK: those residues in Ypk1 that are conserved in at least one of the other kinases are indicated by black letters on a grey background. 
(a) Human enzymes
The ypk1∆ ykr2∆ double mutants carrying pGAL-YKR2 could be maintained on galactose medium, but failed to grow when streaked onto glucose medium, whereas otherwise isogenic wild-type cells or ypk1∆ and ykr2∆ single mutants carrying the same plasmid grew well on glucose ( Figure 5 ). These results confirm that Ypk1 and Ykr2 share some role that is essential for cell growth and survival.
SGK is a functional homologue of Ypk1 and Ykr2
To construct a strain for conveniently testing complementation of the ypk1∆ ykr2∆ double mutant by mammalian protein kinases, the diploid YES7 strain was transformed with a URA3-marked low-copy-number (CEN) plasmid expressing YKR2 from its own promoter, and a haploid ypk1∆ ykr2∆ double mutant strain maintained by expression of YKR2 from the plasmid (strain YPT28) was recovered. The YPT28 strain was then transformed with either empty LEU2-marked, high-copy-number (2 µm DNA) vectors (pAD4M or YEp351GAL) or the same vectors expressing (from either the GAL1 promoter or the constitutive ADH1 promoter [39] ) YPK1, YKR2, or cDNAs encoding rat SGK, mouse PKB/c-AKT, rat p70 S6 kinase, or bovine βARK. All of these strains are able to grow on galactose medium due to the presence of the plasmid expressing YKR2, which also demonstrated that expression of none of the heterologous protein kinases tested was deleterious to yeast cell growth ( Figure 6a ). In contrast, when plated on the same medium containing 5-FOA, thereby demanding loss of the pYKR2(URA3) plasmid, ypk1∆ ykr2∆ cells carrying the empty vectors were unable to grow, whereas those harbouring plasmids expressing either YPK1 or YKR2 remained viable, as expected.
Of the four mammalian cDNAs tested, only SGK displayed efficient complementation by permitting growth on 5-FOA (Figure 6a ). Weak complementation by PKB was reproducibly observed, in that a small percentage of the colonies were able to survive (possibly cells expressing exceedingly high levels of PKB due to elevated copy number of the 2 µm DNA plasmid resulting from its poor segregation efficiency [40] ). Each mammalian protein kinase was produced at a readily detectable level in yeast (grown on SCGal-Leu), as judged by immunoblotting with appropriate antibodies, and was active, as judged by assaying extracts of the yeast cells with appropriate specific substrates (data not shown); hence, the failure of p70 S6 kinase and βARK to complement was not due to their lack of expression. Because p70 S6 kinase is under such complex regulation in animal cells [41, 42] , various aminoterminal and carboxy-terminal truncations [43] were also tested in the same way; although all were expressed, none were able to complement (data not shown). To confirm these results by an independent method, the same plasmids were introduced into a yeast strain (YPT40) that displays temperature-conditional growth because it carries a null mutation in YKR2 (ykr2∆) and a temperature-sensitive (ts) mutation in YPK1 (ypk1-1 ts ). All of the transformants were able to grow at the permissive temperature (26°C). However, the strain carrying an empty vector (YEp351GAL) was unable to survive at the restrictive temperature (35°C), although the strain expressing YPK1 from the same vector grew well ( Figure 6b ). As observed before, the same cells expressing SGK were able to grow well at 35°C. Cells expressing PKB were able to grow weakly, in that microcolonies were observed outside of the heavy initial streak. In contrast, cells expressing p70 S6 kinase or βARK did not grow (Figure 6b ).
Ypk1 and mammalian SGK are efficient substrates for Pkh1
On the basis of the above observations, Ypk1 (and/or Ykr2) should be physiological substrates of Pkh1 (and/or Pkh2). Likewise, as PDK1 is able to phosphorylate and activate SGK [23] , yeast Pkh1 (and/or Pkh2) should be able to phosphorylate and activate mammalian SGK. To test these predictions, Ypk1 and SGK (lacking its aminoterminal 60 amino acids) were expressed as GST fusion proteins in 293 cells and purified. Each purified protein yielded a single band following SDS-PAGE that had the expected molecular mass (data not shown). In the absence of any other factor, purified GST-Ypk1 displayed no
Research Paper S. cerevisiae PDK1 and SGK homologues Casamayor et al. 191
Figure 5
Expression of either Ypk1 or Ykr2 is required for viability. Strain YES7, transformed with the LEU2-marked plasmid, pGAL-YKR2, was sporulated on medium lacking leucine and containing galactose to select for the presence of the plasmid and to induce expression of YKR2 from the plasmid. The four spores of a tetratype ascus (wild type (wt); ypk1∆; ykr2∆; ypk1∆ ykr2∆) derived from this diploid were recovered on this medium (SCGal-Leu) and then subsequently streaked on the same medium containing glucose as the carbon source (SCGlcLeu) to repress expression of the plasmid-borne YKR2 gene.
Current Biology detectable activity towards the crosstide peptide substrate; however, after pre-incubation with purified GST-Pkh1, GST-Ypk1 was activated and catalysed a readily detectable level of incorporation into the substrate, in the presence or absence of lipid vesicles containing PI(3,4,5)P 3 ( Figure 3c ). Consistent with activation resulting from Pkh1-dependent phosphorylation, incorporation of label into GST-Ypk1 was readily detected when [γ-32 P]ATP was included in the reaction and was present exclusively as phosphothreonine (data not shown). A kinase-dead derivative, GST-Ypk1(D488A), was phosphorylated by GST-Pkh1 but, as expected, was not catalytically active (data not shown). Also, as predicted, GST-SGK was both phosphorylated and activated upon incubation in vitro with GST-Pkh1 (Figure 3d ). Moreover, the site phosphorylated in SGK by Pkh1 was mapped to Thr256 (data not shown), the same site as that phosphorylated by PDK1 [23] .
As one means to map the Pkh1 phosphorylation site in Ypk1, a GST-Ypk1(T504D) mutant, which contains a threonine to aspartic acid substitution at position 504 in the presumptive PDK1-like site (Figure 4a ), was expressed in 293 cells and purified. GST-Ypk1(T504D) was not detectably phosphorylated by Pkh1 (Figure 7) , consistent with the conclusion that Pkh1 phosphorylates Ypk1 at this residue. As GST-Ypk1(T504D) was neither constitutively active nor activated by Pkh1, the aspartic acid residue at this position cannot substitute for phosphothreonine in the activation of this protein kinase. A similar result has been obtained for SGK [23] . Ypk1 also contains a putative consensus site (Thr662) for PDK2 phosphorylation (Figure 4a) . A GST-Ypk1 fusion protein containing a threonine to aspartic acid mutation of this site, GST-Ypk1(T662D), was expressed and purified from 293 cells and was also inactive; however, this protein was phosphorylated and activated by Pkh1 in a manner identical to GST-Ypk1 itself ( Figure 7 ). When both Thr504 and Thr662 were mutated to aspartic acid residues, creating GST-Ypk1(T504D T662D), this mutant also displayed no detectable activity (before or after incubation with Mg 2+ -ATP and GST-Pkh1), demonstrating that, unlike PKBα, mutation of these residues to aspartic acid residues cannot substitute for phosphothreonine to produce a constitutively active enzyme. A similar observation has been made for SGK [23] .
Pkh1 acts on Ypk1 in vivo
A functional Ypk1 derivative tagged at its carboxyl terminus with a c-Myc epitope was expressed in cells that were metabolically labelled with [ 32 P]PO 4 3-; the Ypk1 derivative was then immunoprecipitated with the anti-Myc antibody 9E10. When compared with the level of incorporation observed in control (PKH1 + PKH2 + ) cells, labelling of Ypk1 was reproducibly reduced (by 53 ± 20%) in pkh1∆ mutants, but not affected (within 10 ± 5% of control) in pkh2∆ mutants (see Supplementary material published with this paper on the internet). These results suggest that Pkh1 contributes to phosphorylation of Ypk1 in vivo and are consistent with the above findings in vitro. In agreement with these conclusions, overproduction of Pkh1 rescued the inviability of the ypk1-1 ts ykr2∆ strain at the non-permissive temperature, whereas Pkh2 overexpression did not (Figure 8) . Moreover, as would be expected if this suppression arises from a direct physical interaction between Pkh1 and the mutant Ypk1 protein that persists at the restrictive temperature (Figure 8a ), neither overproduced Pkh1 (Figure 8b ) nor overproduced Pkh2 (data not shown) was able to rescue a ypk1∆ ykr2∆ strain, which lacks Ypk1 protein (Figure 8c) . SGK rescues the inviability of ypk1∆ ykr2∆ cells. (a) Strain YPT28 carrying pYKR2, a URA3-marked plasmid that expresses YKR2 from its authentic promoter, was generated and 
Substrate specificities of Ypk1, SGK and PKB are similar
PKBα phosphorylates substrates at the minimal consensus sequence Arg-X-Arg-X-X-S Se er r-Hyd, (where the bold Ser represents the phosphorylated amino acid and Hyd represents a bulky hydrophobic residue) [44] . Likewise, SGK requires arginine at the -5 and -3 positions (numbering with respect to Ser) for efficient phosphorylation, although the requirement for a large hydrophobic residue at +1 is less stringent [23] . Using peptide substrates, the substrate selectivity of Pkh1-activated Ypk1 was quite similar to that of PDK1-activated PKBα and PDK1-activated SGK (Table 1) . For example, mutation of either of the arginine residues, even to lysine residues, drastically reduced phosphorylation by Ypk1.
Discussion
We 
Figure 8
Overexpression of Pkh1 suppresses a temperature-sensitive Ypk1 mutant. (a) As judged by immunoblotting with rabbit polyclonal anti-Ypk1 antibodies, a polypeptide of the size predicted for Ypk1 was present in wild-type cells (wt), absent in a ypk1∆ mutant, overproduced in a cell expressing YPK1 from a constitutive promoter (ADH1) on a multi-copy plasmid (pAD4M), as indicated, and persisted when strain YPT40 (ypk1-1 ts ykr2∆) was grown in rich medium at 30°C and then shifted to the restrictive temperature (37°C) for 3 h. (b) A wild-type strain (W303-1A) carrying a plasmid (pGAL-PKH1-HA), that expresses from the GAL1 promoter a version of Pkh1 tagged with an epitope derived from influenza virus haemagglutinin (HA), was grown in raffinose medium (R), and then a portion shifted to galactose medium (Gal) for 2 h, prior to analysis by SDS-PAGE and immunoblotting with a mouse anti-HA monoclonal antibody. (c) Strains YPT40 (ypk1-1 ts ykr2∆) or YPT28 (ypk1∆ ykr2∆ pYKR2(URA3)) were transformed with the indicated LEU2-marked plasmids. The YPT40 derivatives were streaked on selective medium (SCGal-Leu) and incubated at the indicated temperatures for 3 days. The YPT28 derivatives were streaked on the same medium in the presence or absence of 5-FOA and incubated for 3 days at 30°C. [24] ; nonetheless, expression of PKBα(T308D S473D), with or without its PH domain, is unable to support sustained vegetative growth of either pkh1∆ pkh2∆ or ypk1∆ ykr2∆ cells (A.C, and P.D.T., unpublished observations). Second, high levels of overexpression (~50-fold) of either Ypk1 or Ykr2 from the GAL1 promoter on a multi-copy plasmid does not bypass the need for Pkh1 and Pkh2 function (P.D.T., unpublished observations), suggesting that Pkh1 and/or Pkh2 have other substrates essential for cell viability or that Ypk1 and Ykr2 possess no basal activity at all in the absence of Pkh1-and/or Pkh2-dependent phosphorylation. As we have described here, mutation of Thr504 or Thr662 (or both) to aspartic acid residues does not generate constitutively active Ypk1; likewise, SGK(T256D S422D), which contains the equivalent mutations, is also not constitutively active [23] . Hence, we do not know if constitutive activation of Ypk1 (or SGK) would be sufficient to rescue the lethality of a pkh1∆ pkh2∆ double mutant. A third reason to suspect that Pkh1 and Pkh2 have multiple essential targets is that a potential substrate, Pkc1, is necessary for yeast cell viability under standard growth conditions [37] ; yet, overexpression of PKC1 does not rescue the lethality of pkh1∆ pkh2∆ cells (A.C., unpublished observations). Likewise, absence of another potential Pkh1 and Pkh2 target, Sch9, which serves as an effector enzyme in a pathway parallel to (and largely redundant in function with) the three yeast PKA catalytic subunits (Tpk1, Tpk2 and Tpk3) [36, 49] , is sufficient to cause very slow growth. Tpk1, Tpk2 and Tpk3, which comprise an essential gene set [36] , may themselves be substrates for Pkh1 and/or Pkh2 as all three possess a PDK1-like phosphorylation site [22] .
Like mammalian PDK1 targets, Ypk1 and other suspected substrates for yeast Pkh1 and Pkh2 (except Tpk1, Tpk2 and Tpk3) contain the consensus PDK2 sequence (Phe-X-X-Ar-S Se er r/ /T Th hr r-Ar, where the bold residue is the phosphorylated amino acid and Ar represents an aromatic residue) located at about the same position (160-165 residues carboxy-terminal) relative to the threonine residue phosphorylated by Pkh1. This conservation strongly suggests that S. cerevisiae possesses a PDK2-like activity that may act coordinately with Pkh1 and Pkh2 to modulate the state of activation of a number of target protein kinases, as observed for PDK1 and PDK2 in animal cells.
Since the submission of this manuscript, the identification of the Schizosaccharomyces pombe gene ksg1 has been published. The ksg gene has structural homology with PKH1/PKH2 and is also essential for growth, but is not essential for spore germination [50] .
Materials and methods
Gene disruptions and strain constructions
A PCR-based method [51] was used for disruption of the PKH1 and PKH2 genes. The HIS3 marker was obtained from pRS313, and the TRP1 marker from pRS314 [52] . The ypk1-∆1::HIS3 allele and the ykr2-∆1::TRP1 alleles [45] will be described in greater detail elsewhere (P.D.T., E.A. Schnieders and J.T., unpublished data); in both mutations, the coding sequences for the entire catalytic domains of both enzymes were deleted and replaced with the indicated markers.
To generate a ypk1∆ ykr2∆ double mutant, a MATα ypk1∆ strain (YES5) was mated to a MATa ykr2∆ strain (YES1) carrying pYKR2(URA3) (see below). The resulting diploid was subjected to sporulation and tetrad dissection, and a His + Trp + Ura + spore, representing a MATa ypk1∆ ykr2∆ cell kept alive with the plasmid-borne YKR2 gene, was designated YPT28. To create the temperature-conditional ypk1-1 ts ykr2∆ strain, a temperature-sensitive allele was first generated by error-prone PCR amplification of YPK1 DNA [33] . The linear PCR products were cloned by a procedure that allows for substitution of the potentially mutant YPK1 sequences into a gapped vector, regenerating circular plasmids via recombination with homologous sequences present at each end of the PCR product [53, 54] , and scored for the desired phenotype by a plasmid shuffle procedure [55] . The desired mutant plasmid was recovered [56] and used to construct a HIS3-marked derivative that was integrated in place of the chromosomal YPK1 locus in a ykr2∆ strain, yielding YPT40.
Plasmids
Plasmids for expression of PKH1, YPK1 and SGK, as GST fusions in mammalian 293 cells, were constructed in the vector pEBG-2T [57] . Plasmids for the expression of PKH1 in yeast were constructed in vectors YEplac195 [58] and pYES2 [59] . The vector pYES2 was used to express PKH2 under the control of the GAL1 promoter. To express mammalian PDK1 in yeast under the control of the PKH1 promoter, the PKH1 promoter region was amplified by PCR, fused to a fragment comprising the amino-terminal sequence of PDK1, and the resulting construct used to replace the corresponding segment in plasmids containing either intact PDK1, yielding YEplac195-PDK1, or a derivative of PDK1 lacking its carboxy-terminal PH domain, yielding YEplac195-PDK1-∆PH. The vector pYES2 was used to express genes encoding human PDK1 and PDK1-∆PH under control of the GAL1 promoter. The vector YEp351GAL [60] was used to express YPK1 and YKR2 in yeast under control of the GAL1 promoter. Alternatively, an HA-tagged version of the YPK1 coding sequence, generated by PCR, was inserted into pYES2. A PCR-based method for precise gene fusion [61] was used to generate a Ypk1 derivative tagged at its carboxy-terminal end with the c-Myc epitope recognised by the monoclonal antibody 9E10 [62] . Low-copy-number (CEN) vector pRS316 [51] carrying the URA3 gene was used to express YKR2 under control of its endogenous promoter. Appropriate constructs to express the mammalian protein kinases, rat SGK, mouse PKBα, mouse p70 S6 kinase, and bovine βARK, were constructed in the vectors, pAD4M [63] and YEp351GAL [60] , as indicated in the text. The vector pYES2 was used to express human PKBα [24] and a constitutively active variant of PKBα in which Thr308 and Ser473 were replaced by aspartic acid.
Site-directed mutagenesis
To generate a catalytically inactive (kinase-dead) version of Pkh1 (Pkh1(D267A)), Asp267 was changed to Ala. This position corresponds to a conserved residue critical for recognition of the Mg 2+ -ATP substrate in all protein kinases [8] . Likewise, a catalytically inactive Ypk1 derivative was generated by changing Asp488 (nucleotide sequence GAT) to Ala (GCT). To attempt to generate a constitutively active YPK1 derivative, the Pkh1-dependent phosphorylation site (Thr504) and a presumptive phosphorylation site (Thr662) that matches the consensus for phosphorylation by a PDK2-like enzyme were replaced with aspartic acid.
Expression and purification of GST-Pkh1, GST-Ypk1 and GST-SGK
The 293 human embryonic kidney cell line was cultured on 40 10-cm diameter dishes, and each dish was transfected with 20 µg of the appropriate expression construct using a modified calcium phosphate method [64] . Lysates were prepared and the resulting GST fusion proteins were purified as described previously for GST-PKBα [3] . About 0.5 mg of each purified GST fusion protein was obtained, snap-frozen in aliquots in liquid nitrogen and stored at -80°C.
Measurement of Ypk1, SGK and PKB activities
The assay of Ypk1 activity was carried out in two stages. First (stage 1), GST-Ypk1 was activated by incubation with GST-Pkh1 and Mg 2+ -ATP, as follows. A reaction mixture (18 µl) containing 2.5 µM PKI, 1 µM microcystin-LR, 10 mM Mg-acetate, 100 µM unlabelled ATP and 0.6 µM GST-Ypk1 was prepared in buffer A (50 mM Tris/HCl, pH 7.5, 0.1 mM EGTA, and 0.1% (by vol) 2-mercaptoethanol). The reaction was initiated by addition of 2 µl 50 nM GST-Pkh1 in buffer A containing 1 mg/ml bovine serum albumin, and was incubated at 30°C for 30 min. Second (stage 2), activated Ypk1 was assayed by adding 30 µl of a mixture in buffer A containing 2.5 µM PKI, 1 µM microcystin-LR, 10 mM Mg-acetate, 100 µM [γ 32 P]ATP (200-400 cpm/pmol) and 100 µM crosstide (GRPRTSSFAEG in single-letter amino-acid code) [32] , a peptide phosphoacceptor substrate. After incubation for 15 min at 30°C, the reaction was terminated by spotting a portion (45 µl) of each reaction mixture onto small squares of phosphocellulose paper (Whatman P81), which were washed and analysed as described [65] . Control reactions omitted either GST-Ypk1 or GST-Pkh1 and resulted in incorporation of less than 5% of the radioactivity measured in the presence of both of these proteins. One unit of GST-Ypk1 activity was defined as that amount required to catalyse phosphorylation of 1 nmol crosstide in 1 min. Assay of SGK and PKBα activities were carried out in identical manner, except that GST-SGK and GST-PKBα, respectively, replaced GST-Ypk1 in the first stage of the assay.
Phosphorylation of GST-Ypk1, GST-PKBα and GST-SGK by Pkh1
Incubations were identical to stage 1 of the Ypk1 assay described above, except that [γ-32 P]ATP (500-1,000 cpm/pmol) was used instead of unlabelled ATP, and reactions were terminated by adding SDS to a final concentration of 1%. The resulting samples were resolved on 7.5% SDS-polyacrylamide gels [66] and, after staining with Coomassie blue, analysed by autoradiography. Also, the stained band corresponding to the GST fusion protein of interest was excised and the amount of radioactivity incorporated was quantified by liquid scintillation counting. Ability of GST-Pkh1 to phosphorylate and activate human SGK was examined using methods identical to those described immediately above. For phosphorylation and activation of human PKBα by GST-Pkh1, reactions were performed in the presence of lipid vesicles containing various 3-phosphoinositides [3] , as described in the Results. Lipid abbreviations: SA-PI(3,4,5)P 3 is the Denantiomer of sn-1-stearoyl, 2-arachidonyl PI(3,4,5)P 3 ; DP-PI(3,4,5)P 3 is sn-1,2-dipalmitoyl D-PI(3,4,5)P 3 ; DP-PI(3,4)P 2 is sn-1,2-dipalmitoyl D-PI(3,4)P 2 ; DP-PI(3)P is sn-1,2-dipalmitoyl D-PI(3)P. PI(4,5)P 2 was purified from brain extract.
Determination of Ypk1 substrate specificity
GST-Ypk1 was activated with Pkh1 in vitro and incubated under standard assay conditions, as described above, except that crosstide was replaced by 100 µM of the peptides discussed in detail in the Results. GST-PKBα and GST-SGK, activated by phosphorylation with PDK1 in vitro were assayed in parallel.
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A figure showing the in vivo Pkh1-dependent phosphorylation of Ypk1, a table of the yeast strains used in this study and additional methodological details are published with this paper on the internet.
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Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast
Supplementary materials and methods
Cell culture
S. cerevisiae strains used are described in Table S1 , and were derivatives of either AYS927 (W303 background) or YPH499 (S288C background).
Yeast was grown at 30°C in a rich medium (YPD) containing 1% yeast extract, 2% peptone (Difco) and 2% glucose, or in a synthetic minimal medium (S), containing either galactose (Gal), raffinose (R) or glucose (Glc, or D, for dextrose) as the carbon source, supplemented with nutrients appropriately to maintain selection for markers and plasmids [S1]. Standard methods were used for yeast genetic manipulation [S1,S2] and for plasmid construction and propagation in Escherichia coli [S3] .
Recombinant DNA techniques
Restriction enzyme digests, DNA ligations and other recombinant DNA procedures were performed as described [S3] . Modification of the Li-acetate procedure was used for yeast transformation [S4] . PKH1 and PKH2 genes used in this study, and the YPK1 gene in some constructions, were recovered from genomic DNA of strain AYS927 using PCR amplification, gel-purified, and cloned first into the pCR2.1-TOPO vector (Invitrogen). Site-directed mutagenesis was performed using the QuikChange Kit (Stratagene) following instructions provided by the manufacturer. DNA constructs were verified by automatic DNA sequencing using an automated DNA Sequencer (Model 373; Applied Biosystems).
PCR amplification of yeast genomic DNA
The primers used to amplify the PKH2 coding region were 5′-CGGGATCCGCCACCATGGAGCAGAAGCTGATCTCTGAAGAGG ACTTGTATTTGATAAGGATAATTCCATG-3′ (forward) and 5′-ATAA-GAATGCGGCCGCTTACGACCTCTTCGATTTTGCAG-3′ (reverse), and incorporated BamHI and NotI sites, respectively (indicated by italics). The primers used to amplify the PKH1 coding region were 5′-ATAAGAATGCGGCCGCTGCCACCATGGAGCAGAACCTGTCTCT GAAGAGGACTTGGGAAATAGGTCTTGACAGAGG-3′ (forward) and 5′-ATAAGAATGCGGCCGCTCATTTTTCATCTGTCCGTGTC-3′ (reverse), and incorporated NotI sites (indicated in italics). Both 5′ primers also contained a sequence encoding a 10-residue c-Myc epitope tag (underlined). The primers used to amplify the YPK1 gene were: 5′-GGATCCGCCACCATGTACCCATACGATGTGCCAGAT-TACGCCTATTCTTGGAAGTTTAAG-3′ (forward) and 5′-GGTACCC-TATCTAATGCTTCTACCTTGC-3′ (reverse), and incorporated BamHI and KpnI restriction sites, respectively (italics). The initiator or termination codons in all these primers are also indicated (bold type).
PCR-based gene disruptions and strain constructions
To generate the pkh2∆::HIS3 mutation, HIS3 was amplified from pRS313 [S5] using as primers 5′-AAGTAACATCTTGATGAACCGA-GAAGCCACTAACTAGTTTTGTGCACCATAATTTTCCG-3′ (forward), where the underlined sequence corresponds to nucleotides -93 to -53 from the PKH2 initiator codon and the remainder of the primer corresponds to nucleotides -326 to -311 from the initiator codon of HIS3, and 5′-TAAGTAGCTTGATGAAAACATTAGATAAAATTACTAA-TTACCGTCGAGTTCAAGAG-3′, (reverse) where the underlined sequence corresponds to the nucleotides immediately after the PKH2 stop codon (in bold type) and the remainder corresponds to nucleotides 204-189 after the HIS3 stop codon. The resulting 3.3 kb product was used for DNA-mediated transformation of a diploid strain (AYS927). Transformants were selected on SD-His plates, and disruption was verified by PCR analysis of DNA from one of the His + isolates using appropriate primers. This heterozygous PKH2/pkh2∆::HIS3 diploid (AC200) was sporulated, and the resulting tetrads were dissected. Spore clones were analysed by plating on selective medium and confirmed by PCR to identify a haploid containing the pkh2∆::HIS3 disruption (AC303). To generate the pkh1∆::TRP1 mutation, the TRP1 marker in pRS314 [S5] was amplified using 5′-GCACGTGTACTTGCTTGAATACTGCTACTATATCATTAATATGGTA CTGAGAGTGCACC-3′ (forward), where the underlined sequence corresponds to nucleotides immediately upstream of the initiator codon (bold type) and the remainder corresponds to nucleotides situated -300 to -285 nucleotides from the initiator codon of TRP1, and 5′-TATTATGCATTACACTTTCCCCTTCACCATGTCTTACATATGCATC-CGCAGGCAAGTGCAC-3′ (reverse), where the underlined nucleotides correspond to positions +69 to 25 after the PKH1 stop codon and the remainder of the primer corresponds to the region situated +51 to 36 nucleotides after the TRP1 stop codon. The resulting
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Figure S1
Phosphorylation of Ypk1 in vivo is dependent on Pkh1. Haploid strains AC301 (pkh1∆) and AC303 (pkh2∆), and their otherwise isogenic parent (wt), were transformed, as indicated, with either a vector expressing YPK1 or the same vector expressing Ypk1 tagged with a c-Myc epitope (YPK1m) and metabolically labelled with [ 32 P]PO 4 3-. Whole-cell extracts were prepared, clarified, and then subjected to immunoprecipitation with mouse anti-c-Myc monoclonal antibody 9E10. After extensive washing, duplicate samples of the immunoprecipitates were solubilised, subjected to SDS-PAGE, transferred to a PVDF membrane, and analysed by autoradiography to measure 32 2.4 kb product was used for transformation of AYS927, and transformants were selected on SD-Trp plates. Disruption was verified by PCR analysis from one of the Trp + isolates using appropriate primers. This heterozygous diploid PKH1/pkh1∆::TRP1 (AC201) was sporulated, dissected, analysed, and a haploid spore containing the pkh1∆::TRP1 mutation (AC301) was identified.
Generation of the ypk1-1 ts ykr2∆ strain
To create the temperature-conditional ypk1-1 ts ykr2∆ strain (YPT40), a temperature-sensitive allele of YPK1 was first generated, as follows. A genomic insert containing the YPK1 gene cloned into the XbaI site in the vector, pGEM3 TM (Promega), and generously provided by Richard A. Maurer (then at the University of Iowa) [S6] , was excised as a 4.1 kb XbaI-SalI fragment and inserted into the LEU2-containing vector, pRS315 [S5] , yielding pRS315-YPK1. The sequence encoding the catalytic domain of YPK1 was then amplified under moderately errorprone conditions using AmpliTaq TM DNA polymerase (Perkin Elmer Cetus), with pRS315-YPK1 as the template and a 5′ primer (P1), 5′-TGCCCTCGAAGACATGGC-3′, corresponding to a sequence beginning at nucleotide 788 (where the first base of the ATG start codon is +1) and a 3′ primer (P2), 5′-CTTGAACACAGTAAGTAACGG-3′, corresponding to the flanking genomic sequence commencing 68 bp downstream of the stop codon. The resulting 1350 bp linear PCR product was gel-purified and co-transformed into a haploid ypk1∆ ykr2∆ double mutant carrying pYKR2(URA3) (strain YPT28) along with a ~9 kb linear fragment of pRS315-YPK1, that had been generated by digestion with PstI and NcoI, and gel-purified. Transformants were selected on SCD-Leu plates at 26°C. This procedure allows for replacement of the corresponding sequence in the parent vector with potentially mutant sequences, and regeneration of circular plasmids, via in vivo repair of the gapped plasmid by recombination with homologous sequences present at each end of the PCR product [S7,S8] .
To determine which LEU2-containing plasmids expressed functional YPK1 at 26°C, the Leu + transformants were subsequently replica-plated onto Leu -plates containing 5-FOA to select for loss of the pYKR2(URA3) plasmid initially present in YPT28. To determine which of the YPK1-and LEU2-containing plasmids harboured a temperature-sensitive allele of YPK1, the Leu + Ura -cells were tested by replica-plating for their ability to grow on SCD-Leu plates at 37°C. One transformant was identified that reproducibly failed to grow at this temperature. The LEU2-containing plasmid carried by this strain (pypk1TS) was recovered [S9] , and direct nucleotide sequence analysis of the YPK1 open reading frame in the plasmid revealed the presence of two amino acid substitutions (I484T and Y536C). Subcloning and re-transformation confirmed that these mutations were sufficient to confer the temperature-sensitive (ts) phenotype, and this allele was designated ypk1-1 ts . The ypk1-1 ts allele was used to transplace the normal YPK1 chromosomal locus in the ykr2∆ strain (YES1), as follows. First, PCR was used to generate a customised DNA fragment containing BamHI and SmaI restriction sites 96 and 108 bp, respectively, downstream from the stop codon of the YPK1 coding sequence in pypk1TS plasmid, and this fragment was substituted for the corresponding segment of the 3′-flanking region, yielding pINT. A 2.6 kb ScaI-BamHI fragment containing the HIS3 gene, excised from vector, pRS303 [S5] , was gel-purified and inserted into pINT that had been digested with BamHI and SmaI, yielding pINT-HIS, which was able to confer both leucine and histidine prototrophy to a leu2 his3 strain, YPH499 [S5] . Finally, a 4.6 kb ClaI-XhoI fragment from pINT-HIS, containing the ypk1-1 ts allele, the HIS3 gene, and additional genomic DNA from the YPK1 locus flanking the HIS3 gene to its 3′-side, was gelpurified and used for transformation of YES1. His + transformants were selected at 26°C, The presence of the integrated ypk1-1 ts allele (and the absence of the normal YPK1 locus) was then confirmed by PCR analysis of DNA isolated from the transformants and by demonstrating that such cells were unable to grow at 37°C. One such isolate that met all of these criteria was designated strain YPT40.
Plasmids
For expression of PKH1 and YPK1 as GST fusions in mammalian 293 cells, the corresponding coding sequences were excised from the S2 Supplementary material Table S1 S. cerevisiae strains used in this study. To express mammalian PDK1 in yeast under control of the PKH1 promoter, a 0.7 kb fragment corresponding to the PKH1 promoter region was first amplified by PCR from the YEplac195-PKH1 construct using the primers 5′-GGGGTACCGCTTGACTCAATTAAGGCGAC-3′ (forward) and 5′-CTTCAGAGATCAGCTTCTGCTCCATATTAAT-GATATAGTA-3′ (reverse), corresponding to the start of the PDK1 coding sequence (underlined). Second, a 1.4 kb fragment comprising the amino-terminal sequence of PDK1 was amplified from a human PDK1 cDNA using as primers the 0.7 kb PCR amplification product (forward) and 5′-ACACGATCTCAGCCGTGTAAA A-3′(reverse), corresponding to residues 190-184 of PDK1. The 1.4 kb product was cleaved at the KpnI site (italics) and also with HindIII, which cleaves at an internal site in the PDK1 coding sequence. The resulting KpnI-HindIII fragment was used to replace a 0.5 kb segment encoding the amino-terminal end of the PDK1 protein either in a construct containing the complete PDK1 coding sequence, yielding YEplac195-PDK1, or in a construct containing just the first 404 residues of the PDK1, corresponding to its catalytic domain and lacking its carboxyterminal PH domain, generating YEplac195-PDK1-∆PH. To express human PDK1 under control of the GAL1 promoter, a 2.0 kb BglII-XbaI fragment containing the complete PDK1 coding sequence was inserted into pYES2, yielding pYES2-PDK1. Similarly, a 1.4 kb BglII-XbaI fragment containing the kinase domain of PDK1, but lacking the PH domain, was inserted into pYES2, creating pYES2-PDK1-∆PH.
To express YKR2 in yeast from a LEU2-marked, high-copy-number (2 µm DNA-based) plasmid under control of the GAL1 promoter, a 2.4 kb XhoI-HindIII fragment of genomic DNA containing the entire YKR2 open reading frame [S15] was excised from an insert in pUC18 (generously provided by Shigeo Ohno, Department of Molecular Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo) and ligated into the vector, YEp351GAL [S16] , that had been linearised by digestion with SalI and HindIII, yielding pGAL-YKR2. An essentially identical approach was used to express YPK1, excised from a genomic DNA fragment (see above), yielding pGAL-YPK1, which was constructed by Henrik Dohlman (Thorner laboratory). Alternatively, a 2.1 kb BamHI-NotI fragment encoding an HA-tagged version of the YPK1 coding sequence, generated by PCR, was inserted into pYES2, yielding pYES2-YPK1. To place the YKR2 gene under control of its endogenous promoter on a low-copy-number (CEN) plasmid carrying the URA3 gene, a 2.5 kb EcoRI-EcoRI fragment of the original YKR2-containing insert in pUC18 was ligated into the vector, pRS316 [S5] , that had been linearised with EcoRI, generating pYKR2(URA3). To generate a version of Ypk1 tagged at its carboxyl terminus with the cMyc epitope recognised by the monoclonal antibody 9E10 [S17], a PCR-based method for precise gene fusion [S18] was performed using the YPK1 sequence cloned in pGEM3 as one template, and, as the other template, a sequence encoding the 16-residue version of the Myc epitope followed by a His 6 tag cloned in pBluescript (Stratagene), generously provided by Elana Swartzman (Thorner laboratory), and three appropriate synthetic oligonucleotide primers: P1; T3 (Stratagene), 5′-AATTAACCCTCACTAAAGGG-3′, corresponding to sequences in the pBluescript vector; and, a 'joiner' primer (P3), 5′-TTCAGAAATCAACTTTTGTTCTCTAATGCTTCTACCTTGC-3′, corresponding to the 3′-end of the YPK1 coding sequence and the first several residues of the c-Myc epitope. A 2 kb ClaI-SalI fragment of the resulting product was used to replace the corresponding segment in the original YPK1-containing pGEM3 vector [S6] , yielding pYPK1myc. A 1.2 kb NcoI-HindIII fragment of pYPK1myc was used to replace the corresponding segment of pGAL-YPK1, yielding pGAL-YPK1myc.
To express SGK in yeast, a 1.3 kb NcoI-EcoRI fragment encoding a rat SGK cDNA [S19] (generously provided by Gary Firestone, Department of Molecular and Cell Biology, University of California, Berkeley, California) was converted to blunt ends by treatment with the Klenow fragment of E. coli DNA polymerase I in the presence of dNTPs and inserted behind the ADH1 promoter in the vector pAD4M [S20] that had been linearised with SmaI. Correct orientation of the fragment was confirmed by appropriate restriction enzyme digests. An essentially identical approach was used to express bovine βARK, yielding pADH-βARK, which was constructed by Henrik Dohlman (Thorner laboratory). To express PKB in yeast, a 1.5 kb BamHI-BamHI fragment encoding mouse c-Akt was excised from an insert in a two-hybrid bait vector, pASIIA (supplied by Zhou Songyang, Department of Biology, Massachusetts Institute of Technology, Cambridge), and ligated into YEp351GAL that had been linearised by digestion with BamHI, yielding pGAL-PKB. Alternatively, a 2.5 kb EcoRI-XbaI fragment encoding a human PKBα cDNA [S21] was inserted into pYES2, generating pYES2-PKBα. In addition, a 1.5 kb EcoRI-XbaI insert expressing a constitutively active mutant version of PKBα [S22] , in which Thr308 and Ser473 have been replaced by aspartic acid residues, was inserted into pYES2, creating pYES2-DD-PKBα. To express p70 S6K in yeast, a 1.6 kb XbaI-SalI fragment encoding rat p70 S6K [S23] was excised from p2B4 (kindly provided by George Thomas, Friedrich Miescher Institute, Basel, Switzerland) and inserted into YEp351GAL that had been linearised by digestion with XbaI-SalI, yielding pGAL-S6K. In addition, an amino-terminal truncation, a carboxy-terminal truncation, and a double amino-and carboxy-terminal truncation of p70 S6 kinase (generously provided by John Blenis, Department of Cell Biology, Harvard Medical School, Boston), whose constructions are described in detail elsewhere [S24] , were also inserted into a yeast expression vector, YEp352 [S25] , each under control of the methionine-repressible MET3 promoter [S26] using essentially identical methods.
Plasmid pPKH1-HA was constructed by PCR as follows: Primers 5′-TGCGCTCGAGATGGGAAATAGGTCTTTG-3′ (underlined bases correspond to an introduced XhoI site, and start codon in italics) and 5′-CGCATGCATTAGCGGCCGCCTTTTTCATCTGTCCGTG-3′ (underlined bases correspond to an introduced NsiI site, italic bases the stop codon, and bold bases correspond to an introduced NotI site) were used to amplify the entire open reading frame of PKH1 from pYES2-PKH1. This 2.2 kb PCR fragment was then digested with XhoI and NsiI and ligated into vector YEp351GAL that had been digested with SalI and PstI. The resulting plasmid, pPKH1, contained a NotI site just before the stop codon to permit in-frame insertion of a fragment encoding three tandem HA epitope tags, which were excised as a NotI fragment from a plasmid described elsewhere [S27] . Orientation of the tag was confirmed by sequencing. Plasmid pPKH2-HA was constructed by PCR in a very similar manner, using primers 5′-TGCGGGATCCATGTATTTTGATAAGGATAAT-3′, (underlined bases correspond to an introduced BamHI site, start codon in italics) and Supplementary material S3 5′-CCGCTCGAGTTAGCGGCCGCCCGACCTCTTCGATTTTG-3′ (underlined bases correspond to an introduced XhoI site, italic bases the stop codon, and bold bases correspond to an introduced NotI site) to amplify the entire open reading frame of PKH2 from pYES2-PKH2. The 3.2 kb PCR fragment was then digested with BamHI and XhoI and ligated to vector YEp351GAL that had been digested with BamHI and SalI.
Radiolabeling of yeast cells and immunoprecipitation of Ypk1 from cell extracts
Yeast strains harbouring pGAL-YPK1myc were grown at 30°C to midexponential phase in raffinose-containing minimal medium, supplemented with all L-amino acids and nucleotides (except Leu and Ura). The cells were collected, diluted into galactose-containing low phosphate medium [S28] , grown to mid-exponential phase, collected, concentrated 10-fold and incubated for 2.5 h with 0.5-1 mCi of 32 PO 4 3-. Radiolabeled cells were collected by brief sedimentation in a clinical centrifuge, washed with PBS and resuspended in ice-cold extraction buffer containing a mixture of phosphoprotein phosphatase inhibitors and protease inhibitors that has been described [S29] . Extracts were prepared and Ypk1-Myc protein was immunoprecipitated with the 9E10 anti-c-Myc monoclonal antibody, according to methods described in detail elsewhere [S30] . The final washed immune complexes were resuspended in 15 µl SDS-PAGE sample buffer, and heated to 90°C for 5 min. Samples were clarified by centrifugation for 2 min in a microfuge, and the supernatant solution (typically ~25 µl) was subjected to electrophoresis on a 8% polyacrylamide gel in the presence of SDS. Autoradiography of dried gels or PVDF filter replicas was performed using either X-ray film or a Phosphorimager (Storm TM ; Molecular Dynamics), according to procedures recommended by the manufacturer.
Antisera
A rabbit polyclonal anti-Ypk1 antiserum (#1446) was raised against a GST-Ypk1 fusion protein containing the first 115 residues of Ypk1, expressed in and purified from E. coli. For immunoblotting, the antiserum was used at 1:3,000 dilution. Other antisera used in this study were the gifts of other investigators.
